Health condition
Benign peripheral nerve tumours - schwannomas, neurofibromas, and why most need no treatment at all.
A slow-growing, painless lump along a nerve is usually a schwannoma or a neurofibroma - not cancer. MRI confirms the picture, and most people simply need watchful waiting.
Why trust this guide
- 01
Editorial team
Written by our editorial team from the UK sources listed on each page.
- 02
Sourced from guidance
Checked against NICE, NHS and peer-reviewed neurosurgical and dermatological sources you can see at the end.
- 03
Current for 2026
Reflects modern UK practice on watchful waiting, MRI characterisation and nerve-sparing surgery for benign nerve tumours.
Key facts
Benign nerve tumours at a glance.
The essentials, in plain English - what these lumps are, how they behave, and how they're managed in the UK today.
-
What it is
A benign, non-cancerous growth arising from the cells that make up or surround a peripheral nerve - most commonly a schwannoma or a neurofibroma.
-
Two main types
Schwannomas (encapsulated, arise from Schwann cells) and neurofibromas (unencapsulated, can be solitary or multiple in NF1).
-
Behaviour
Usually slow-growing and stable for years - unlike malignant peripheral nerve sheath tumours (MPNST), which grow rapidly and invade.
-
Typical presentation
A painless, palpable lump along the course of a nerve, sometimes with mild tingling or a positive Tinel's sign on tapping.
-
Most common approach
Watchful waiting with periodic review for small, asymptomatic, stable lesions - the majority of cases.
-
NF1 consideration
People with neurofibromatosis type 1 can develop multiple neurofibromas and need longer-term monitoring for the small lifetime risk of malignant change.
Why this guide matters
A calm approach to an alarming-sounding lump.
Finding a lump along a nerve is unsettling, but the great majority of these are benign, stable, and never need surgery. The three points below shape everything else on this page.
-
Benign is the common outcome
Schwannomas and neurofibromas are far more common than malignant nerve sheath tumours, and MRI usually tells the two apart with confidence.
-
Watchful waiting is often the plan
Small, stable, asymptomatic lesions are usually simply monitored - not every lump needs a scalpel.
-
Surgery, when needed, protects the nerve
Modern microsurgical technique aims to remove the tumour while preserving the nerve fascicles and normal function.
How the diagnosis is made
From a noticed lump to a confident answer.
The steps a UK GP, neurologist or specialist will normally follow, in order - so you know what to expect and why.
Phase 1 · Assessing
History, examination and family history
Phase 2 · Confirming
Imaging and characterisation
Phase 3 · Deciding
Referral or biopsy if needed
- 01
Assessing
History and examination
When the lump was first noticed, how quickly (if at all) it has grown, and whether there is pain, tingling, numbness or weakness.
- 02
Assessing
Tinel's sign
Gently tapping over the lump can reproduce tingling or an electric sensation along the nerve - a helpful clue that it arises from a nerve.
- 03
Assessing
Family and skin history
Café-au-lait patches, axillary freckling or a family history of neurofibromatosis raise the possibility of NF1-related neurofibromas.
- 04
Confirming
MRI to characterise the lesion
The key imaging test - looking for well-circumscribed margins, a "target sign" or "split-fat sign" and steady, non-invasive growth typical of benign disease.
- 05
Confirming
Ultrasound as a first look
Often used for superficial, easily accessible lumps to confirm a nerve origin before MRI, especially where MRI access is limited.
- 06
Confirming
Assessing for concerning features
Rapid growth, new pain, a size increase on serial imaging, or an NF1 background prompt closer scrutiny for possible malignant transformation.
- 07
Deciding
Biopsy or specialist referral
Any atypical feature is referred to a specialist nerve or sarcoma service - biopsy or excision biopsy confirms the diagnosis when imaging alone is not conclusive.
Typical timeline: a first visit to a confirmed diagnosis on MRI, usually within a few weeks.
Symptoms
What a benign nerve tumour actually feels like.
Usually quiet and unremarkable - a lump that stays the same for years. And the features that mean it's time for a closer look.
-
Painless palpable lump
A firm, mobile swelling felt along the line of a nerve - often the only sign, found incidentally or on self-examination.
-
Mild tingling or pins and needles
Occasional paraesthesia in the distribution of the affected nerve, usually mild and intermittent rather than constant.
-
Positive Tinel's sign
Tapping over the lump reproduces an electric, tingling sensation - a classic sign the lump is nerve-related.
-
Slow, stable growth
Most benign nerve tumours change very little over months to years - a reassuring pattern on serial review.
-
Occasional mild discomfort
Ache or tenderness with pressure, tight clothing or prolonged activity, though most lesions stay asymptomatic.
-
Multiple lesions in NF1
People with neurofibromatosis type 1 may have dozens of cutaneous or subcutaneous neurofibromas of varying size.
-
Localised weakness (uncommon)
Rarely, a larger lesion presses on motor fibres and causes mild weakness in the muscles supplied by that nerve.
-
Red flag - rapid growth or new pain
A lesion that grows quickly, becomes painful, or changes character - especially in NF1 - needs urgent specialist assessment for MPNST.
Treatment
How benign nerve tumours are managed in the UK.
Watchful waiting for most, careful nerve-sparing surgery for those who need it, and longer-term monitoring where NF1 is part of the picture.
-
Watchful waiting
The default for small, asymptomatic, stable lesions with reassuring MRI features - reviewed periodically rather than treated straight away.
-
Periodic clinical review
Repeat examination, and sometimes repeat imaging, at intervals to confirm the lesion remains unchanged over time.
-
Surgical excision - symptomatic disease
Offered when a lesion causes pain, tingling, weakness or functional impairment that affects daily life.
-
Surgical excision - diagnostic certainty
Considered when imaging cannot fully exclude a more concerning lesion, or the patient wants a firm histological diagnosis.
-
Nerve-sparing microsurgical technique
Schwannomas can often be shelled out from the nerve with the fascicles preserved, since they arise from a single fascicle or the nerve sheath rather than replacing the whole nerve.
-
Intraoperative nerve monitoring
Used during excision of larger or deeper lesions to help the surgeon avoid injuring functioning nerve fascicles.
-
Debulking for multiple neurofibromas
In NF1, very large or numerous lesions may be selectively debulked for symptom relief or cosmetic reasons rather than fully excised.
-
Long-term surveillance in NF1
Regular monitoring of existing neurofibromas, with prompt review of any lesion that changes, given the small lifetime risk of malignant transformation.
What this guide is based on
The sources behind every claim on this page.
UK national guidance and specialist society standards, current at the time of last review.
Key references
Guidelines and standards we relied on.
A quiet reminder
This guide is for information, not medical advice.
Your GP or specialist knows your history and imaging and can tell you which parts apply to you. If in doubt, get seen.
-
NICE. Neurofibromatosis type 1: recognition, referral and management (NG191).
-
NHS. Neurofibromatosis type 1 - overview and monitoring.
-
British Neurosurgical guidance on peripheral nerve sheath tumours.
-
Peer-reviewed literature on schwannoma and neurofibroma diagnosis and management.
Red flags
When a nerve lump needs urgent attention.
Most benign nerve tumours are safely watched. These are the situations that aren't - and where a specialist opinion is needed promptly, to rule out a malignant peripheral nerve sheath tumour.
-
Rapid increase in size
A lump that visibly grows over weeks rather than years is atypical for a benign nerve tumour and needs urgent review.
-
New or worsening pain
Benign lesions are usually painless - new, persistent or worsening pain is a signal to reassess promptly.
-
Progressive neurological deficit
New weakness, numbness or loss of function in the area supplied by the nerve warrants urgent specialist assessment.
-
Change in a known NF1 neurofibroma
Any established neurofibroma that starts growing, hardening or becoming painful should be reviewed for possible malignant transformation (MPNST).
-
Lesion greater than 5cm or deep-seated
Larger, deep lesions carry a higher index of suspicion and are usually referred for specialist imaging and opinion.
-
Systemic symptoms
Unexplained weight loss, night sweats or fatigue alongside a nerve lump are not typical of benign disease and need prompt investigation.
-
Multiple café-au-lait patches or freckling
A skin pattern suggestive of undiagnosed NF1 alongside a nerve lump merits genetic and specialist referral.
-
Family history of MPNST
A family history of malignant nerve sheath tumours should prompt closer surveillance of any new or existing lesion.
-
Failed conservative management
Ongoing symptoms despite reassurance and observation are a reason to revisit the diagnosis and consider excision.
Living with it
A stable condition, with a simple watch-and-wait plan.
Four things that make the biggest difference day to day - reassurance, keeping review appointments, noticing change early, and understanding your surgical options if you need them.
A quiet reminder
Stable means stable - not a countdown to something worse.
A lump that has not changed on review after review is doing exactly what a benign nerve tumour is expected to do.
- 01 Reassure
Most lumps stay exactly as they are
The great majority of benign nerve tumours never grow, never become painful and never need surgery.
- 02 Monitor
Keep review appointments
Simple, periodic checks - sometimes with repeat imaging - are how stability gets confirmed over time.
- 03 Notice
Report any change promptly
New pain, faster growth or new tingling or weakness are worth telling your clinician about as soon as you notice them.
- 04 Plan
Ask about nerve-sparing surgery
If excision is needed, ask how the surgical team plans to protect nerve function during the operation.
Frequently asked
Everything we get asked about benign nerve tumours.
Quick answers on schwannomas, neurofibromas, imaging, surgery and NF1 monitoring.
-
What is a benign peripheral nerve tumour?
A non-cancerous growth arising from the cells of a peripheral nerve or its surrounding sheath. The two main types are schwannomas, which arise from Schwann cells and are usually encapsulated, and neurofibromas, which are unencapsulated and can occur alone or in multiples as part of neurofibromatosis type 1 (NF1). Both are typically slow-growing and stable.
-
How is a benign nerve tumour different from a malignant one?
Benign tumours such as schwannomas and neurofibromas are usually well-circumscribed, slow-growing and painless. Malignant peripheral nerve sheath tumours (MPNST) tend to grow rapidly, cause new pain, invade surrounding tissue and are more common in people with NF1. Any of these features prompts urgent specialist assessment.
-
Do I need surgery for a schwannoma or neurofibroma?
Not usually. Small, asymptomatic, stable lesions are typically managed with watchful waiting and periodic review. Surgery is considered if the lump is symptomatic, causing functional impairment, or if there is diagnostic uncertainty that imaging cannot resolve.
-
Will surgery damage the nerve?
Surgeons use careful microsurgical technique, and often intraoperative nerve monitoring, to shell out the tumour while preserving the healthy nerve fascicles. Schwannomas in particular can usually be removed with the nerve function preserved, though some risk of temporary or, rarely, permanent numbness or weakness remains.
-
What is Tinel's sign and why does it matter?
Tinel's sign is a tingling or electric sensation felt when a clinician gently taps over a lump. A positive sign suggests the lump arises from a nerve, supporting a diagnosis of schwannoma or neurofibroma rather than an unrelated soft-tissue lump.
-
I have NF1 - how often should my neurofibromas be checked?
People with NF1 are usually offered regular clinical review, since there is a small lifetime risk that a neurofibroma can transform into a malignant peripheral nerve sheath tumour. Your specialist team will agree a monitoring schedule and will want to know promptly about any lesion that changes in size, texture or symptoms.
Related content
Keep reading.
-
Peripheral Nerve Tumours
The broader guide to all peripheral nerve tumours, benign and malignant.
Learn more -
Nerve Sheath Tumors
How schwannomas and neurofibromas fit within the nerve sheath tumour family.
Learn more -
Malignant Peripheral Nerve Sheath Tumors
The rarer, aggressive counterpart to watch for.
Learn more -
Nerve Compression
When a nearby structure - not a tumour - presses on a nerve.
Learn more -
Nerve Pain
Understanding neuropathic pain and its causes.
Learn more -
Function Loss From Old Nerve Injury
Related nerve condition guide.
Learn more -
All conditions
Browse every clinical guide.
Learn more -
Mole Mapping
Related diagnostic test for skin and soft-tissue lesions.
Learn more